LACTULOSE COOPER 66.5 %, oral solution bottle, 200 ml
Active ingredients: Β-lactulose, LACTULOSE LIQUIDE
Commercialized according to BDPM
Oral solutionbottle, 200 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LACTULOSE COOPER 66,5 %, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 200 ml avec gobelet(s) doseur(s) polypropylène
- Marketing authorisation holder
- COOPER CONSUMER NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 May 2017
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66952196CIP73737379CIP133400937373791Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LACTULOSEsolution | 3,335 g · 5 ml | FT |
| LACTULOSE LIQUIDEsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.